These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2675895)

  • 1. Azathioprine-cyclosporin A (CyA) double therapy versus CyA alone after the first rejection episode in kidney-transplanted patients under CyA. A randomized study.
    Hourmant M; Taupin JL; Leymerigie F; Cantarovich D; Soulillou JP
    Transpl Int; 1989 Aug; 2(2):113-6. PubMed ID: 2675895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the addition of azathioprine (Aza) to CyA monotherapy after a first rejection prevent a second rejection episode in kidney transplant patients?
    Hourmant M; Taupin JL; Leymerigie F; Cantarovich D; Soulillou JP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1589-90. PubMed ID: 2652517
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine as primary therapy for A-matched living related donor kidney graft recipients.
    MacDonald AS; Belitsky P; Bitter-Suermann H; Cohen A
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1667-9. PubMed ID: 2652546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal allograft immunosuppression. II. A randomized trial of withdrawal of one drug in triple drug immunosuppression.
    Isoniemi H; Ahonen J; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Häyry P
    Transpl Int; 1990 Oct; 3(3):121-7. PubMed ID: 2271083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of 54 renal allograft recipients in the cyclosporin A era. What influences acute rejection episode and long-term graft survival?].
    Tanda K; Takeuchi I; Chikaraishi T; Togashi M; Koyanagi T; Kanagawa K; Hirano T; Seki T; Tsubo S
    Nihon Hinyokika Gakkai Zasshi; 1992 Dec; 83(12):1970-7. PubMed ID: 1474704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.
    Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Keavey S; Turcotte JG; Campbell DA
    Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Mycophenolate Mofetil Acute Renal Rejection Study Group
    Transplantation; 2001 Apr; 71(8):1091-7. PubMed ID: 11374408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal allograft immunosuppression. I. Early inflammatory and rejection episodes in triple drug treatment compared to double drug combinations or cyclosporin monotherapy.
    Isoniemi H; Ahonen J; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Häyry P
    Transpl Int; 1990 Jul; 3(2):92-7. PubMed ID: 2206227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion from cyclosporin to azathioprine 3 months after renal transplantation--is it safe?
    Cassidy MJ; Irving E; Swanepoel CR; Pascoe MD; van Zyl-Smit R; Jacobson JE
    S Afr Med J; 1986 Sep; 70(6):317-8. PubMed ID: 3529454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Sutherland DE; Fryd DS; Strand MH; Canafax DM; Ascher NL; Payne WD; Simmons RL; Najarian JS
    Am J Kidney Dis; 1985 Jun; 5(6):318-27. PubMed ID: 3893106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective randomised comparative study on the influence of cyclosporin and azathioprine on renal allograft survival and function.
    Henny FC; Kootte AM; Van Bockel JH; Baldwin WM; Hermans J; Bos B; van Es LA; Paul LC
    Nephrol Dial Transplant; 1986; 1(1):44-9. PubMed ID: 3110662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin a as sole immunosuppressive agent in recipients of kidney allografts from cadaver donors. Preliminary results of a European multicentre trial.
    Lancet; 1982 Jul; 2(8289):57-60. PubMed ID: 6123806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A in pediatric kidney transplantation and its effect on posttransplantation growth.
    Brodehl J; Offner G; Hoyer PF; Schirg E; Pichlmayr R; Wonigeit K
    Nephron; 1986; 44(1):26-31. PubMed ID: 3528879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years.
    Johnson CP; Simmons RL; Sutherland DE; Canafax DM; Ascher NL; Payne WD; Flick B; Najarian JS; Fryd DS
    Transplantation; 1988 Feb; 45(2):380-5. PubMed ID: 3278431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of delayed cyclosporin A in after administration of anti-lymphocyte serum in kidney transplantation].
    Hourmant M; Soulillou JP
    Biomed Pharmacother; 1987; 41(5):247-9. PubMed ID: 3311191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transplant conversion from cyclosporin to azathioprine: effect on cardiovascular risk profile.
    Sutherland F; Burgess E; Klassen J; Buckle S; Paul LC
    Transpl Int; 1993 May; 6(3):129-32. PubMed ID: 8499063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that addition of azathioprine improves renal function in cyclosporine-treated patients with allograft dysfunction.
    Pascual J; Marcén R; Orofino L; Quereda C; Mampaso F; Liaño F; Ortuño J
    Transplantation; 1991 Aug; 52(2):276-9. PubMed ID: 1871800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Najarian JS; Fryd DS; Strand M; Canafax DM; Ascher NL; Payne WD; Simmons RL; Sutherland DE
    Ann Surg; 1985 Feb; 201(2):142-57. PubMed ID: 3882063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of immunosuppression by serum inhibition of alloreaction and measurement of cyclosporin A (CyA) serum levels in kidney graft recipients under CyA.
    Chabannes D; Vernillet L; Cantarovich D; Humbert H; Vie H; Soulillou JP
    Transpl Int; 1990 Dec; 3(4):189-94. PubMed ID: 2076168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.